Helius Medical Technologi... (HSDT)
NASDAQ: HSDT
· Real-Time Price · USD
0.26
0.02 (8.33%)
At close: May 01, 2025, 3:52 PM
8.33% (1D)
| Bid | 0.26 |
| Market Cap | 1.59M |
| Revenue (ttm) | 520K |
| Net Income (ttm) | -11.74M |
| EPS (ttm) | -4.33 |
| PE Ratio (ttm) | -0.06 |
| Forward PE | -0.69 |
| Analyst | Buy |
| Ask | 0.27 |
| Volume | 253,377 |
| Avg. Volume (20D) | 125,993 |
| Open | 0.24 |
| Previous Close | 0.24 |
| Day's Range | 0.24 - 0.28 |
| 52-Week Range | 0.22 - 3.68 |
| Beta | 1.28 |
About HSDT
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic...
Industry Medical - Devices
Sector Healthcare
IPO Date Jun 27, 2014
Employees 21
Stock Exchange NASDAQ
Ticker Symbol HSDT
Website https://heliusmedical.com
Analyst Forecast
According to 2 analyst ratings, the average rating for HSDT stock is "Buy." The 12-month stock price forecast is $24, which is an increase of 9130.77% from the latest price.
Stock ForecastsNext Earnings Release
Helius Medical Technologies Inc. is scheduled to release its earnings on May 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 day ago
-15.19%
Helius Medical Technologies shares are trading low...
Unlock content with
Pro Subscription
3 months ago
+37.15%
Helius Medical Technologies shares are trading higher after the company announced it exceeded its initial enrollment target for its stroke pivotal study.
